Abbott To Acquire Cephea Valve Technologies, Inc.
Acquisition to further bolster Abbott's leading position in therapies for mitral valve disease, the most common type of heart valve ailment
ABBOTT PARK, Ill., Jan. 16, 2019 -- (Healthcare Sales & Marketing Network) -- Abbott (NYSE: ABT) announced today... Devices, Interventional, Cardiology, Mergers & Acquisitions Abbott, Cephea Valve Technologies, Mitral valve, heart valve
Source: HSMN NewsFeed - Category: Pharmaceuticals Source Type: news
More News: Cardiology | Heart | Heart Valve Disease | Heart Valves | Marketing | Mergers and Aquisitions | Pharmaceuticals